Anima Biotech's guest appearances

Anima Biotech

ForbesBooks Radio

Disruptive CEO Nation

BioBoss

BioTech IQ

LifeSci Partners Presents: Benchtop Bios

Kevin Lee

John Dawson

Panna Sharma

George Goldsmith

Andrew Hall

Erika Smith

Yochi Slonim

Shawn Singh

Ankit Mahadevia

John Houston

Yuval Cohen

Sven Karlsson

Liang Schweizer

Florian Wegener

Martin Mackay

OwlTail

With pandemics and global health concerns in the headlines, it is good to know there are companies like Anima Biotech leveraging advanced technology to accelerate pharma solutions. Under the leadership of Co-founder and CEO Yochi Slonim, the team at Anima Biotech is advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs and their mechanisms of action. If you do not understand what this means, take a listen as we promise you will be fascinated and learn something new.In this episode, we discussed:- How Yochi made the leap to founding a company that is at the leading edge of the intersection of technology and medical discovery.- How using AI and machine learning is a complete game changer in #medtech.- Why mRNA Lightening is so critical to the swift discovery and treatability process for existing and evolving diseases.- How their differentiated approach combines high-scale phenotypic screening that automates millions of experiments in live mRNA biology with MOAi technology using AI to elucidate the mechanism of action of active molecules.- Why the best people and best solutions require a global team to make up Anima and so their eye is on expansion and partner networks.Yochi Slonim is a serial entrepreneur in software and biotech who has built multiple companies through all phases of growth all the way to IPOs and large M&amp;A exits. As a Co-founder and CEO of Anima Biotech, he is driving the company's vision and strategy, fundraising, and partnering.Prior to Anima, Yochi was a co-founder of Mercury Interactive. As CTO and VP R&amp;D from the company's early days, he created product vision and strategy and led a multi-product organization of 200 developers. After going public and reaching revenues of over $1B annually, Mercury was acquired by HP for $4.5B.In 2000, Yochi was the founder and CEO of Identify. The company reached revenues of $50m in less than 5 years and was acquired by BMC in 2006 for $150m in cash. Yochi founded ffwd.me, a unique startup acceleration program where he led a team that worked with over 25 startups in diverse areas and technologies, developing strategy, products and go-to-market operations while raising multiple rounds of financing from VCs and private investors. Be sure to check out Yochi’s links listed below. Enjoy the show!Connect with Yochi:LinkedIn: https://www.animabiotech.com/Website: https://www.linkedin.com/in/yochislonim/?originalSubdomain=il Connect with Allison:LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/Website: DisruptiveCEONation.comTwitter: @DisruptiveCEO  #CEO #startup #startupstory #founder #founderstory #business #construction #businesspodcast #podcast Learn more about your ad choices. Visit megaphone.fm/adchoices

With pandemics and global health concerns in the headlines, it is good to know there are companies like Anima Biotech leveraging advanced technology to accelerate pharma solutions. Under the leadership of Co-founder and CEO Yochi Slonim, the team at Anima Biotech is advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs and their mechanisms of action. If you do not understand what this means, take a listen as we promise you will be fascinated and learn something new. In this episode, we discussed:- How Yochi made the leap to founding a company that is at the leading edge of the intersection of technology and medical discovery.- How using AI and machine learning is a complete game changer in #medtech.- Why mRNA Lightening is so critical to the swift discovery and treatability process for existing and evolving diseases.- How their differentiated approach combines high-scale phenotypic screening that automates millions of experiments in live mRNA biology with MOAi technology using AI to elucidate the mechanism of action of active molecules.- Why the best people and best solutions require a global team to make up Anima and so their eye is on expansion and partner networks.Yochi Slonim is a serial entrepreneur in software and biotech who has built multiple companies through all phases of growth all the way to IPOs and large M&amp;A exits. As a Co-founder and CEO of Anima Biotech, he is driving the company's vision and strategy, fundraising, and partnering.Prior to Anima, Yochi was a co-founder of Mercury Interactive. As CTO and VP R&amp;D from the company's early days, he created product vision and strategy and led a multi-product organization of 200 developers. After going public and reaching revenues of over $1B annually, Mercury was acquired by HP for $4.5B.In 2000, Yochi was the founder and CEO of Identify. The company reached revenues of $50m in less than 5 years and was acquired by BMC in 2006 for $150m in cash. Yochi founded <a href="http://ffwd.me" rel="nofollow" target="_blank">ffwd.me</a>, a unique startup acceleration program where he led a team that worked with over 25 startups in diverse areas and technologies, developing strategy, products and go-to-market operations while raising multiple rounds of financing from VCs and private investors. Be sure to check out Yochi’s links listed below. Enjoy the show!Connect with Yochi:LinkedIn: <a href="https://www.animabiotech.com/" rel="nofollow" target="_blank">https://www.animabiotech.com/</a>Website: <a href="https://www.linkedin.com/in/yochislonim/?originalSubdomain=il" rel="nofollow" target="_blank">https://www.linkedin.com/in/yochislonim/?originalSubdomain=il</a> Connect with Allison:LinkedIn: <a href="https://www.linkedin.com/in/allisonsummerschicago/" rel="nofollow" target="_blank">https://www.linkedin.com/in/allisonsummerschicago/</a>Website: <a href="http://DisruptiveCEONation.com" rel="nofollow" target="_blank">DisruptiveCEONation.com</a>Twitter: @DisruptiveCEO  #CEO #startup #startupstory #founder #founderstory #business #construction #businesspodcast #podcast Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="nofollow" target="_blank">megaphone.fm/adchoices</a>

Episode 179 Yochi Slonim, Co-founder & CEO of Anima Biotech, Bernardsville, New Jersey with offices in Israel, UK and UAE

On this episode of BioTech IQ Ammon talks with Co-Founder and CEO of Anima Biotech, Yochi Slonim. Yochi is a serial entrepreneur with experience building multiple successful companies before starting Co-Founding Anima. Anima Biotech is developing mRNA Lighting, a novel platform for the discovery of selective small molecule mRNA drugs and their mechanisms of action. Automated high scale phenotypic screening combining live biology with AI mRNA image analysis for the discovery of small molecule mRNA drugs and their mechanisms of action.https://www.animabiotech.com/Catch the latest on BioTech IQhttps://thebiotechiqpodcast.com/ Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/

On this episode of BioTech IQ Ammon talks with Co-Founder and CEO of Anima Biotech, Yochi Slonim. Yochi is a serial entrepreneur with experience building multiple successful companies before starting Co-Founding Anima. Anima Biotech is developing mRNA Lighting, a novel platform for the discovery of selective small molecule mRNA drugs and their mechanisms of action. Automated high scale phenotypic screening combining live biology with AI mRNA image analysis for the discovery of small molecule mRNA drugs and their mechanisms of action. <a href="https://www.animabiotech.com/" rel="nofollow" target="_blank">https://www.animabiotech.com/</a> Catch the latest on BioTech IQ <a href="https://thebiotechiqpodcast.com/" rel="nofollow" target="_blank">https://thebiotechiqpodcast.com/</a> <a href="https://www.buzzsprout.com/1208600/support" rel="payment nofollow" target="_blank">Support the show</a>Check me out on LinkedIn <a href="https://www.linkedin.com/in/ammonr/" rel="nofollow" target="_blank">https://www.linkedin.com/in/ammonr/</a>

#52 How is Anima Biotech changing the game on identifying the mechanism of action?

BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&amp;D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&amp;D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

#44 - Yochi Slonim: Founder & CEO, Anima Biotech